Hematopoietic stem cell cytokine control of developmental vascularization

造血干细胞细胞因子控制发育血管化

基本信息

  • 批准号:
    8402619
  • 负责人:
  • 金额:
    $ 36.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-01-03 至 2014-12-31
  • 项目状态:
    已结题

项目摘要

In this new proposal, we investigate our novel finding that a unique combination of hematopoietic stem cell cytokines (i.e. stem cell factor-SCF; interleukin 3- IL-3; and stromal-derived factor-1 alpha- SDF-1¿) control human endothelial cell (EC) tube morphogenesis and EC-pericyte tube coassembly under defined serum-free conditions (and in the absence of phorbol ester) in 3D collagen matrices. Interestingly, VEGF has no influence by itself and requires the synergistic action of these hematopoietic factors in order to exert an effect on EC sprouting, its major morphogenic influence. We propose the hypothesis that SCF, IL-3 and SDF-1¿ are critical regulators of vascular morphogenesis which act in a synergistic manner and are necessary cofactors for the action of known mediators of developmental vascularization (e.g. VEGF and BMP-4). Combined administration of c-Kit (the SCF receptor) and CXCR4 (the SDF-1¿ receptor) inhibitors or blocking antibodies to SCF and IL-3 leads to vascular hemorrhage phenotypes in developing quail embryos that relates to defects in vessel formation and remodeling. Also, we show that the three factors synergize to activate Src, B-Raf and Erk kinases and induce the expression of the ¿2¿1 integrin and Pak2 which are known regulators of vascular morphogenesis. We will elucidate the molecular basis for the signaling synergism of the three cytokines in ECs, how these factors interface with VEGF, BMP-4, and pericytes to control EC sprouting and how they affect both ECs and pericytes during tube coassembly and maturation events in vitro and in vivo. We propose three specific aims which are; Specific Aim #1. To elucidate the signaling mechanisms by which SCF, IL-3 and SDF-1¿ synergize to stimulate vasculogenic EC tube assembly in 3D extracellular matrices. Specific Aim #2. To determine how SCF, IL-3 and SDF-1¿ affect VEGF and BMP-4 signaling to control EC sprouting responses in 3D extracellular matrices. Specific Aim #3. To determine how SCF, IL-3 and SDF-1¿ act to regulate pericyte-induced EC sprouting responses and vasculogenic EC-pericyte tube coassembly in 3D extracellular matrices.
在这个新的提案中,我们调查了我们的新发现,即一种独特的造血干细胞组合 细胞细胞因子(即干细胞因子-SCF、白介素3-IL-3和基质衍生因子-1α-SDF-1) 控制人内皮细胞(EC)管形态发生和EC-周细胞管共组装 确定了3D胶原蛋白基质中的无血清条件(以及在不存在佛波酯的情况下)。 有趣的是,血管内皮生长因子本身没有影响,需要这些造血因子的协同作用。 为了对EC的萌发起作用,它的主要形态发生影响。我们提出这样的假设: SCF、IL-3和SDF-1是血管形态发生的关键调节因子,它们以协同的方式发挥作用,并 是已知的发育血管形成介质作用的必要辅助因子(例如,血管内皮生长因子和 BMP-4)。C-Kit(SCF受体)和CXCR4(SDF-1受体)抑制剂联合应用或 阻断抗SCF和IL-3抗体导致发育中的鹌鹑胚胎血管出血表型 这与血管形成和重塑中的缺陷有关。此外,我们还表明,这三个因素协同作用 激活Src、B-Raf和Erk激酶,诱导已知的整合素和Ak2的表达 血管形态发生的调节剂。我们将阐明信号协同作用的分子基础。 内皮细胞中的三种细胞因子,这些因子如何与血管内皮生长因子、骨形态发生蛋白-4和周细胞相互作用来控制内皮细胞的萌发 以及它们在体外和体内的管子共组装和成熟事件中如何影响内皮细胞和周细胞。 我们提出了三个具体目标: 具体目标1.阐明SCF、IL-3和SDF-1协同作用的信号机制 在3D细胞外基质中刺激血管生成EC管组装。 具体目标2.确定SCF、IL-3和SDF-1如何影响血管内皮细胞生长因子和骨形态发生蛋白-4信号转导 EC在3D细胞外基质中的萌发反应。 具体目标#3.确定SCF、IL-3和SDF-1如何调节周细胞诱导的EC 3D细胞外基质中的萌发反应和血管生成EC-周细胞管共组装。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

George E Davis其他文献

Talin1 is required for cardiac Z-disk stabilization and endothelial integrity in zebrafish.
Talin1 是斑马鱼心脏 Z 盘稳定和内皮完整性所必需的。
  • DOI:
    10.1096/fj.15-273409
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Qing Wu;Jiaojiao Zhang;Wonshill Koh;Qingming Yu;Xiaojun Zhu;Adam Amsterdam;George E Davis;M Amin Arnaout;Jing-Wei Xiong
  • 通讯作者:
    Jing-Wei Xiong

George E Davis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('George E Davis', 18)}}的其他基金

Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
调节血管畸形的有缺陷的周细胞-内皮细胞相互作用的分子基础
  • 批准号:
    10192817
  • 财政年份:
    2020
  • 资助金额:
    $ 36.06万
  • 项目类别:
Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
调节血管畸形的有缺陷的周细胞-内皮细胞相互作用的分子基础
  • 批准号:
    10619624
  • 财政年份:
    2020
  • 资助金额:
    $ 36.06万
  • 项目类别:
Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
调节血管畸形的有缺陷的周细胞-内皮细胞相互作用的分子基础
  • 批准号:
    10408085
  • 财政年份:
    2020
  • 资助金额:
    $ 36.06万
  • 项目类别:
Novel growth factor and signaling requirements for human capillary tube assembly
人体毛细管组装的新型生长因子和信号传导要求
  • 批准号:
    9102169
  • 财政年份:
    2015
  • 资助金额:
    $ 36.06万
  • 项目类别:
Novel growth factor and signaling requirements for human capillary tube assembly
人体毛细管组装的新型生长因子和信号传导要求
  • 批准号:
    8942261
  • 财政年份:
    2015
  • 资助金额:
    $ 36.06万
  • 项目类别:
Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
  • 批准号:
    8021934
  • 财政年份:
    2011
  • 资助金额:
    $ 36.06万
  • 项目类别:
Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
  • 批准号:
    8207865
  • 财政年份:
    2011
  • 资助金额:
    $ 36.06万
  • 项目类别:
Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
  • 批准号:
    8593308
  • 财政年份:
    2011
  • 资助金额:
    $ 36.06万
  • 项目类别:
Molecular and Cellular Biology Core
分子和细胞生物学核心
  • 批准号:
    7918622
  • 财政年份:
    2010
  • 资助金额:
    $ 36.06万
  • 项目类别:
Molecular Control of EC Lumen Formation by MT1-MMP
MT1-MMP 对 EC 腔形成的分子控制
  • 批准号:
    7373336
  • 财政年份:
    2008
  • 资助金额:
    $ 36.06万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.06万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.06万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.06万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.06万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.06万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.06万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.06万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.06万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.06万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.06万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了